PPIH Expression Correlates with Tumor Aggressiveness and Immune Dysregulation in Hepatocellular Carcinoma
This study emphasizes PPIH's critical role in HCC progression by facilitating tumor growth and survival while modulating the immune landscape, thereby positioning PPIH as a potential therapeutic target for HCC management.
Authors
- Yihu Li (ORCID: https://orcid.org/0000-0001-7049-8631)
- Xinkun Huang
- Jiaxin Bei (ORCID: https://orcid.org/0000-0003-4108-3749)
- Yongyou Luo
- Rongdang Fu
- Zhisheng Wei (ORCID: https://orcid.org/0000-0002-9141-9418)
- Ye Chen (ORCID: https://orcid.org/0000-0003-4265-7396)
- Zihao Sun (ORCID: https://orcid.org/0009-0000-5915-8871)
- J. D. Huang (ORCID: https://orcid.org/0000-0002-8453-4610)
Institutions
- Second Affiliated Hospital of Guangzhou Medical University (CN)
- First People's Hospital of Foshan (CN)
- First Affiliated Hospital of Guangdong Pharmaceutical University (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Journal of Hepatocellular Carcinoma
- Published
- 2024-12-01
- DOI
- https://doi.org/10.2147/jhc.s492420
- Citations
- 1
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.23